319 related articles for article (PubMed ID: 32097528)
1. ZMYND11-related syndromic intellectual disability: 16 patients delineating and expanding the phenotypic spectrum.
Yates TM; Drucker M; Barnicoat A; Low K; Gerkes EH; Fry AE; Parker MJ; O'Driscoll M; Charles P; Cox H; Marey I; Keren B; Rinne T; McEntagart M; Ramachandran V; Drury S; Vansenne F; Sival DA; Herkert JC; Callewaert B; Tan WH; Balasubramanian M
Hum Mutat; 2020 May; 41(5):1042-1050. PubMed ID: 32097528
[TBL] [Abstract][Full Text] [Related]
2. Intragenic Deletion of the ZMYND11 Gene in 10p15.3 is Associated with Developmental Delay Phenotype: A Case Report.
Huynh MT; Tran CT; Joubert M; Bénéteau C
Cytogenet Genome Res; 2021; 161(8-9):445-448. PubMed ID: 34818214
[TBL] [Abstract][Full Text] [Related]
3. ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder.
Oates S; Absoud M; Goyal S; Bayley S; Baulcomb J; Sims A; Riddett A; Allis K; Brasch-Andersen C; Balasubramanian M; Bai R; Callewaert B; Hüffmeier U; Le Duc D; Radtke M; Korff C; Kennedy J; Low K; Møller RS; Nielsen JEK; Popp B; Quteineh L; Rønde G; Schönewolf-Greulich B; Shillington A; Taylor MR; Todd E; Torring PM; Tümer Z; Vasileiou G; Yates TM; Zweier C; Rosch R; Basson MA; Pal DK
Clin Genet; 2021 Oct; 100(4):412-429. PubMed ID: 34216016
[TBL] [Abstract][Full Text] [Related]
4. Further Delineation of Clinical Phenotype of
Bodetko A; Chrzanowska J; Rydzanicz M; Borys-Iwanicka A; Karpinski P; Bladowska J; Ploski R; Smigiel R
Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397245
[TBL] [Abstract][Full Text] [Related]
5. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
[TBL] [Abstract][Full Text] [Related]
6. Three patients with DeSanto-Shinawi syndrome: Further phenotypic delineation.
Uehara T; Ishige T; Hattori S; Yoshihashi H; Funato M; Yamaguchi Y; Takenouchi T; Kosaki K
Am J Med Genet A; 2018 Jun; 176(6):1335-1340. PubMed ID: 29663678
[TBL] [Abstract][Full Text] [Related]
7. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8.
Yasin H; Gibson WT; Langlois S; Stowe RM; Tsang ES; Lee L; Poon J; Tran G; Tyson C; Wong CK; Marra MA; Friedman JM; Zahir FR
J Hum Genet; 2019 Apr; 64(4):271-280. PubMed ID: 30670789
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome.
Vasileiou G; Vergarajauregui S; Endele S; Popp B; Büttner C; Ekici AB; Gerard M; Bramswig NC; Albrecht B; Clayton-Smith J; Morton J; Tomkins S; Low K; Weber A; Wenzel M; Altmüller J; Li Y; Wollnik B; Hoganson G; Plona MR; Cho MT; ; Thiel CT; Lüdecke HJ; Strom TM; Calpena E; Wilkie AOM; Wieczorek D; Engel FB; Reis A
Am J Hum Genet; 2018 Mar; 102(3):468-479. PubMed ID: 29429572
[TBL] [Abstract][Full Text] [Related]
9. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
[TBL] [Abstract][Full Text] [Related]
10. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
[TBL] [Abstract][Full Text] [Related]
11. Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome.
Carlston CM; Bleyl SB; Andrews A; Meyers L; Brown S; Bayrak-Toydemir P; Bale JF; Botto LD
Am J Med Genet A; 2019 May; 179(5):792-796. PubMed ID: 30773818
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.
Asadollahi R; Zweier M; Gogoll L; Schiffmann R; Sticht H; Steindl K; Rauch A
Eur J Med Genet; 2017 Sep; 60(9):451-464. PubMed ID: 28645799
[TBL] [Abstract][Full Text] [Related]
13. WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features.
Skraban CM; Wells CF; Markose P; Cho MT; Nesbitt AI; Au PYB; Begtrup A; Bernat JA; Bird LM; Cao K; de Brouwer APM; Denenberg EH; Douglas G; Gibson KM; Grand K; Goldenberg A; Innes AM; Juusola J; Kempers M; Kinning E; Markie DM; Owens MM; Payne K; Person R; Pfundt R; Stocco A; Turner CLS; Verbeek NE; Walsh LE; Warner TC; Wheeler PG; Wieczorek D; Wilkens AB; Zonneveld-Huijssoon E; ; Kleefstra T; Robertson SP; Santani A; van Gassen KLI; Deardorff MA
Am J Hum Genet; 2017 Jul; 101(1):139-148. PubMed ID: 28686853
[TBL] [Abstract][Full Text] [Related]
14. Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.
Cafiero C; Marangi G; Orteschi D; Ali M; Asaro A; Ponzi E; Moncada A; Ricciardi S; Murdolo M; Mancano G; Contaldo I; Leuzzi V; Battaglia D; Mercuri E; Slavotinek AM; Zollino M
Eur J Hum Genet; 2015 Nov; 23(11):1499-504. PubMed ID: 25712080
[TBL] [Abstract][Full Text] [Related]
15. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
16. A de novo mutation in ZMYND11, a candidate gene for 10p15.3 deletion syndrome, is associated with syndromic intellectual disability.
Cobben JM; Weiss MM; van Dijk FS; De Reuver R; de Kruiff C; Pondaag W; Hennekam RC; Yntema HG
Eur J Med Genet; 2014; 57(11-12):636-8. PubMed ID: 25281490
[TBL] [Abstract][Full Text] [Related]
17. Further delineation of the rare GDACCF (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies syndrome): genotype and phenotype of 22 patients with
Szakszon K; Lourenco CM; Callewaert BL; Geneviève D; Rouxel F; Morin D; Denommé-Pichon AS; Vitobello A; Patterson WG; Louie R; Pinto E Vairo F; Klee E; Kaiwar C; Gavrilova RH; Agre KE; Jacquemont S; Khadijé J; Giltay J; van Gassen K; Merő G; Gerkes E; Van Bon BW; Rinne T; Pfundt R; Brunner HG; Caluseriu O; Grasshoff U; Kehrer M; Haack TB; Khelifa MM; Bergmann AK; Cueto-González AM; Martorell AC; Ramachandrappa S; Sawyer LB; Fasel P; Braun D; Isis A; Superti-Furga A; McNiven V; Chitayat D; Ahmed SA; Brennenstuhl H; Schwaibolf EM; Battisti G; Parmentier B; Stevens SJC
J Med Genet; 2024 Jan; 61(2):132-141. PubMed ID: 37580113
[TBL] [Abstract][Full Text] [Related]
18. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
[TBL] [Abstract][Full Text] [Related]
19. SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression.
Szczałuba K; Brzezinska M; Kot J; Rydzanicz M; Walczak A; Stawiński P; Werner B; Płoski R
Am J Med Genet A; 2016 Sep; 170(9):2322-7. PubMed ID: 27375234
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.
Chaudhry A; Noor A; Degagne B; Baker K; Bok LA; Brady AF; Chitayat D; Chung BH; Cytrynbaum C; Dyment D; Filges I; Helm B; Hutchison HT; Jeng LJ; Laumonnier F; Marshall CR; Menzel M; Parkash S; Parker MJ; ; Raymond LF; Rideout AL; Roberts W; Rupps R; Schanze I; Schrander-Stumpel CT; Speevak MD; Stavropoulos DJ; Stevens SJ; Thomas ER; Toutain A; Vergano S; Weksberg R; Scherer SW; Vincent JB; Carter MT
Clin Genet; 2015 Sep; 88(3):224-33. PubMed ID: 25131214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
